CSL Limited (OTCMKTS:CSLLY) Short Interest Update

CSL Limited (OTCMKTS:CSLLY) saw a large decline in short interest in May. As of May 31st, there was short interest totalling 11,200 shares, a decline of 22.2% from the May 15th total of 14,400 shares. Based on an average daily trading volume, of 68,900 shares, the days-to-cover ratio is currently 0.2 days.

CSL Stock Down 0.1 %

Shares of CSLLY stock traded down $0.10 during midday trading on Friday, reaching $95.23. 24,657 shares of the company were exchanged, compared to its average volume of 30,779. CSL has a 12 month low of $71.51 and a 12 month high of $99.95. The company’s 50 day moving average price is $92.18 and its two-hundred day moving average price is $93.31.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.